Tokiyoshi Tanegashima
Papers
4
Total Citations
13
H-Index
3
About
Dr. Tokiyoshi Tanegashima is a pioneering urologic oncologist whose research is reshaping the surgical management of prostate cancer. His work centers on optimizing the precision and outcomes of radical prostatectomy and pelvic lymph node dissection, with a particular focus on balancing oncologic control with quality of life. Dr. Tanegashima’s most significant contributions lie in refining surgical decision-making. His highly cited 2024 study on optimizing the side of extended pelvic lymph node dissection for unilateral prostate cancer provides a novel framework for predicting contralateral lymph node involvement, potentially sparing patients unnecessary surgery. He has also made landmark contributions to salvage therapy, authoring a seminal 2024 paper on salvage robot-assisted radical prostatectomy following carbon ion radiotherapy—a technically demanding procedure for which he established key surgical and oncologic outcomes. Additionally, his 2023 validation of optimal PSA monitoring schedules after radical prostatectomy offers a practical, evidence-based tool for early detection of biochemical recurrence. With over a dozen citations in just two years, Dr. Tanegashima’s work is rapidly gaining recognition for its direct impact on clinical practice, offering surgeons and patients more personalized, data-driven pathways for prostate cancer treatment.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4